Try our Advanced Search for more refined results
Intellectual Property
- 
									September 24, 2025
									AML Software Sues Athena Bitcoin Over Source Code TheftAML Software has filed a copyright infringement suit against ATM operator Athena Bitcoin for allegedly misappropriating its proprietary bitcoin ATM source code without authorization. 
- 
									September 24, 2025
									USPTO Touts Declining Patent Backlog, Eyes Bigger DropU.S. Patent and Trademark Office officials said Wednesday that its backlog of unexamined patent applications has shrunk this year after new initiatives to reduce it were put in place, and the office has set a goal of steeper drops in the years to come. 
- 
									September 24, 2025
									EcoFactor Tells Justices Patent Rules Usurp Role Of JuriesThe Federal Circuit has created stringent patent-specific rules limiting damages testimony that improperly displace the role of juries, EcoFactor Inc. has told the U.S. Supreme Court, in a bid to undo a decision scrapping the company's $20 million win against Google. 
- 
									September 24, 2025
									NY Appeals Court Backs Drug Co.'s $6.5M Contract Case WinA New York state appeals court won't disturb a finding that a South Korean logistics firm owes $6.5 million for breaching a deal allowing it to license and sell a RedHill Biopharma Ltd. COVID-19 treatment in the country. 
- 
									September 24, 2025
									Swimmers, Divers Rip School, NIL Deal After Team DroppedFour former swimming and diving team members at California Polytechnic State University have filed objections in federal court to the NCAA's $2.78 billion name, image and likeness settlement, after university officials pointed to the financial consequences of the settlement as the reason the swimming and diving program was eliminated. 
- 
									September 24, 2025
									Course Hero Operator Must Face School's Copyright, TM ClaimsCourse Hero, a study platform where users upload materials, must face copyright and trademark claims after a Connecticut federal judge found that a for-profit Connecticut university has demonstrated enough possible harm to justify standing for alleged copyright violations, and that a 2003 U.S. Supreme Court decision does not stand in the way of its Lanham Act claims. 
- 
									September 24, 2025
									Arcturus Sues AbbVie, Capstan Alleging Trade Secret TheftArcturus Therapeutics Inc. has sued AbbVie and Capstan Therapeutics in California federal court, alleging Capstan used Arcturus' proprietary lipid nanoparticle technology to develop and patent competing drug delivery systems, which AbbVie later acquired in a $2.1 billion deal. 
- 
									September 24, 2025
									Fed. Circ. Vacates $181M Patent Verdict Against AT&T, NokiaThe Federal Circuit on Wednesday wiped out Finesse Wireless' $181 million verdict against AT&T and Nokia, finding issues in "confusing and unclear" expert testimony that had supported the case accusing the wireless carriers of infringing a pair of radio interference patents. 
- 
									September 24, 2025
									IP Feud Over 'Shark Tank'-Backed Comb Settles Before TrialThe inventor of a hair-twisting system that was featured on an episode of "Shark Tank" and received an investment from celebrity businessman Mark Cuban has settled patent infringement claims with a rival a week before the two were to go to trial. 
- 
									September 24, 2025
									Merrill Lynch Accuses Ex-Staff, Schwab, Investor Of IP TheftMerrill Lynch has filed a trade secrets lawsuit against a dozen former employees, Charles Schwab and Dynasty Financial Partners, alleging the defendants conspired to start a new independent financial advisory firm with Merrill's staff and confidential information. 
- 
									September 24, 2025
									Microsoft Cleared In Software Patent Case In UtahA Utah federal judge has cleared Microsoft of allegations that it infringed on claims in a patent covering an application for previewing how user commands will affect a computer document, finding that the claims were invalid in light of an earlier invention. 
- 
									September 24, 2025
									Innoscience Claims ITC Ban Over Invalidated Patent Is 'Unjust'Innoscience is urging the Federal Circuit to free it from a U.S. International Trade Commission import ban, saying the Efficient Power Conversion Corp. semiconductor patent it allegedly infringes isn't valid. 
- 
									September 24, 2025
									Judge Says No Dispute Exists In Video File Licensing CaseA Delaware federal judge has granted dismissal to DivX LLC in a case brought by a former business ally who was seeking a declaration that it didn't run afoul of a licensing agreement between the two, saying the court has no jurisdiction in the matter. 
- 
									September 24, 2025
									ITC's IP Cases Mainly Target Computer And Telecom ProductsNew data from the U.S. International Trade Commission has shown that intellectual property activity at the agency in 2024 remained relatively the same, with investigations primarily looking into computer and telecommunications products. 
- 
									September 24, 2025
									Blank Rome Hires Bicoastal Pair Of Patent AttysBlank Rome LLP announced Tuesday that it has welcomed two new patent attorneys to its ranks: a Los Angeles-based firm alum and a New York-based former Leason Ellis LLP lawyer. 
- 
									September 24, 2025
									Judge Sends Pandora IP Claims Back To Special MasterA California federal judge has sent summary judgment motions from online radio service Pandora Media and a group of comedians back to a special master for further consideration after it was previously recommended that Pandora prevail. 
- 
									September 24, 2025
									Labcorp, Natera Resolve DNA Sequencing IP Suits MidtrialLabcorp and Natera have reached a midtrial settlement over the laboratory testing giant's claims that its competitor infringed a group of DNA sequencing patents through the sale of a cancer testing product, a Delaware federal judge said. 
- 
									September 24, 2025
									Ex-Patent Commissioner Is Latest To Move To Private PracticeThe U.S. Patent and Trademark Office's former patent commissioner, who resigned from her position in February as the president slashed the federal workforce, has joined McDermott Will & Schulte as a counsel in Washington, D.C., the firm announced. 
- 
									September 23, 2025
									CBP Says It Didn't Coordinate With Apple In Import Ban CaseU.S. Customs and Border Protection told a D.C. federal court Monday that contrary to claims by Masimo Corp., emails between the agency and Apple Inc. do not show the two worked together to evade an import ban on the Apple Watch in a patent dispute with Masimo. 
- 
									September 23, 2025
									Eli Lilly Deal In Weight Loss Drugs Trademark Suit Hits SnagPharmaceutical giant Eli Lilly and two Seattle-area medical clinics tried to leave a federal court "entirely in the dark" on the finer points of their newly proposed trademark suit settlement, a Seattle federal judge held in declining to approve the deal and enter a consent judgment in the case. 
- 
									September 23, 2025
									Sandisk Gets Support In 'Settled Expectations' ChallengeIndustry groups, professors and Unified Patents are backing Sandisk Technologies Inc.'s Federal Circuit challenge to the U.S. Patent and Trademark Office's policy of denying review of patents based on the owner's "settled expectations," saying it flouts the law and undermines the patent review system. 
- 
									September 23, 2025
									Daybreak Wins Injunction Over EverQuest CopycatThe company behind the online game EverQuest has been granted a preliminary injunction in California federal court against individual defendants over an unauthorized emulator of the game that allegedly makes use of copyrighted content. 
- 
									September 23, 2025
									Fed. Circ. Gives Bayer Chance To Save Xarelto Patent ClaimsThe Federal Circuit revived several claims of a patent underpinning Bayer Pharma Aktiengesellschaft's blockbuster blood thinner Xarelto on Tuesday, sending the challenge brought by Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc. and a Cipla unit back to the Patent Trial and Appeal Board. 
- 
									September 23, 2025
									Apple Gets Judge To Ax MyPort Patent Suit Under AliceA Delaware federal court on Tuesday tossed for now MyPort Technologies Inc.'s lawsuit claiming Apple Inc. infringed four patents with its smartphones and tablets, finding all the patents were just "conventional." 
- 
									September 23, 2025
									How Attys Are Riding The Mass. Biotech 'Roller Coaster'The first half of 2025 saw the Massachusetts biotech industry post bleak numbers, including a dip in venture capital funding and merger activity, leaving attorneys looking for creative ways to help companies with fewer public and private dollars. 
Expert Analysis
- 
								
								Adapting To PTAB's Reembracing Of Discretionary Denials  Recent guidance from the U.S. Patent and Trademark Office marks a swing back toward procedural discretion in Patent Trial and Appeal Board trial institution decisions, bringing unpredictability but also opportunities for drafting petitions, and making and responding to discretionary denial arguments, says Taylor Stemler at Merchant & Gould. 
- 
								
								Crisis Management Lessons From The Parenting Playbook  The parenting skills we use to help our kids through challenges — like rehearsing for stressful situations, modeling confidence and taking time to reset our emotions — can also teach us the fundamentals of leading clients through a corporate crisis, say Deborah Solmor at the Wisconsin Alumni Research Foundation and Cara Peterman at Alston & Bird. 
- 
								
								4 Ways To Leverage A Jury's Underdog Perceptions  Counsel should consider how common factors that speak to their client's size, power, past challenges and alignment with jurors can be presented to try and paint their client as a sympathetic underdog, says Ken Broda-Bahm at Persuasion Strategies. 
- 
								
								4 Legislative Proposals Reflect Growing Scrutiny Of Pharma IP  Bipartisan legislative momentum in Congress, including a recent package of bills targeting exclusivity strategies that delay generic and biosimilar competition, signals growing scrutiny of life sciences intellectual property strategies, so biologics companies and investors must pay attention to new strategic, compliance and litigation risks, says Olga Berson at Thompson Coburn. 
- 
								
								Why Hiring Former Jurors As Consultants Can Be Risky  The defense team's decision to hire former juror Victoria George in the high-profile retrial of Karen Read shines a spotlight on this controversial strategy, which raises important legal, ethical and tactical questions despite not being explicitly prohibited, says Nikoleta Despodova at ND Litigation. 
- 
								Series Adapting To Private Practice: From NY Fed To BigLaw  While the move to private practice brings a learning curve, it also brings chances to learn new skills and grow your network, requiring a clear understanding of how your skills can complement and contribute to a firm's existing practice, and where you can add new value, says Meghann Donahue at Covington. 
- 
								
								What Businesses Need To Know About EU Design Law Reform  Recent reforms to European Union design protection law will broaden the scope of what constitutes protected designs and products, likely creating new opportunities and considerations for businesses operating within the EU or those engaging with its markets, say lawyers at Foley & Lardner. 
- 
								
								Berry Ruling Shows Why Plant IP Suits Can Be Thorny  A California federal court's recent decision in Driscoll's v. California Berry Cultivars illustrates that while a path exists for asserting U.S. plant patent rights against extraterritorial breeders, it can be difficult to prove infringement based on importation of plant parts, say Travis Bliss and Stephany Small at Panitch Schwarze. 
- 
								
								7 Considerations For Conducting Drug Clinical Trials Abroad  With continuing cuts to U.S. Food and Drug Administration staffing motivating some pharmaceutical companies to consider developing drugs abroad, it's important to understand the additional risks and compliance requirements associated with conducting clinical studies in other countries, say attorneys at Morgan Lewis. 
- 
								
								Top 3 Litigation Finance Deal-Killers, And How To Avoid Them  Like all transactions, litigation finance deals can sometimes collapse, but understanding the most common reasons for failure, including a lack of trust or a misunderstanding of deal terms, can help both parties avoid problems, say Rebecca Berrebi at Avenue 33 and Boris Ziser at Schulte Roth. 
- 
								
								Best Practices For Companies Integrating Existing IP With AI  Some copyright owners are exploring how they can make new content by combining their existing intellectual property assets with generative artificial intelligence, and although these initiatives can serve multiple business goals, those considering such practices should be aware they are entering largely uncharted waters, says Josh Weigensberg at Pryor Cashman. 
- 
								
								How Attys Can Use A Therapy Model To Help Triggered Clients  Attorneys can lean on key principles from a psychotherapeutic paradigm known as the "Internal Family Systems" model to help manage triggered clients and get settlement negotiations back on track, says Jennifer Gibbs at Zelle. 
- 
								
								How Athletes Can Protect Their Signature Celebrations As IP  As copyright and trademark law adapts to short-form choreography and dynamic media, athletes and their business partners have new tools to protect the intellectual property embedded in their unique dances, poses and celebrations, say attorneys at Debevoise. 
- 
								Opinion Third-Party Funding Transparency Is Key In Patent Suits  Third-party litigation funding is a growing industry that could benefit from enhanced disclosure standards to ensure transparency, as challenges in obtaining discovery of such funding can complicate patent litigation against nonpracticing entities, say attorneys at Skadden. 
- 
								
								How Attorneys Can Make The Most Of A Deposition Transcript  With recent amendments to federal evidence rules now in effect, it’s more important than ever to make sure that deposition transcripts are clear and precise, and a few key strategies can help attorneys get the most out of a transcript before, during and after a deposition, says Allison Rocker at Baker McKenzie.